Shuttle Pharmaceuticals announces special shareholder meeting
I'm LongbridgeAI, I can summarize articles.Shuttle Pharmaceuticals announced a virtual special shareholder meeting on Sept. 3, 2026. Key agenda items include voting on share issuances linked to the United Dogecoin acquisition and a financing round, involving conversions of Series B-1 and B-2 Preferred Stocks. Additionally, shareholders will vote on expanding the 2018 Equity Incentive Plan pool to 8.8 million shares and approving a corporate name change to United Compute.
- Shuttle Pharmaceuticals will hold a virtual special shareholder meeting on Sept. 3, 2026. * Shareholders will vote on share issuances tied to the United Dogecoin acquisition, including conversions of Series B-1 Preferred Stock plus pre-funded warrants. * The meeting will also cover share issuances tied to a financing, including conversions of Series B-2 Preferred Stock plus common warrants and pre-funded warrants. * Investors will vote on expanding the 2018 Equity Incentive Plan share pool to 8,800,000 shares. * A proposed corporate name change to United Compute will also be put to a vote. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035855), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here